Presentation is loading. Please wait.

Presentation is loading. Please wait.

Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses  Volker Steger, MD, Ute Mika, Heikki Toomes, MD, Tobias Walker, MD, Corinna.

Published byGiles James Modified over 5 years ago

Similar presentations

Presentation on theme: "Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses  Volker Steger, MD, Ute Mika, Heikki Toomes, MD, Tobias Walker, MD, Corinna."— Presentation transcript:

1 Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses 
Volker Steger, MD, Ute Mika, Heikki Toomes, MD, Tobias Walker, MD, Corinna Engel, Thomas Kyriss, MD, Gerhard Ziemer, MD, Godehard Friedel, MD  The Annals of Thoracic Surgery  Volume 83, Issue 6, Pages (June 2007) DOI: /j.athoracsur Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Survival analysis according to a Karnofsky index that exceeds 60% (solid line) compared with a Karnofsky index of 60% or less (dashed line; p < ). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Survival analysis breast cancer (dashed line) compared with all other malignancies (solid line; p = ). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Survival analysis malignant disease (dashed line) compared with benign disease (solid line; p < ). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses  Volker Steger, MD, Ute Mika, Heikki Toomes, MD, Tobias Walker, MD, Corinna."

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Management of Malignant Pleural Effusions Using the Pleurx Catheter

Management of Malignant Pleural Effusions Using the Pleurx Catheter
Giant Transdiaphragmatic Intercostal Hernia

Giant Transdiaphragmatic Intercostal Hernia
The STS National Database

The STS National Database
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,
Bilateral Double Free-Flaps for Reconstruction of Extensive Chest Wall Defect  Emre Gazyakan, MD, Holger Engel, MD, Marcus Lehnhardt, MD, PhD, Michael.

Bilateral Double Free-Flaps for Reconstruction of Extensive Chest Wall Defect  Emre Gazyakan, MD, Holger Engel, MD, Marcus Lehnhardt, MD, PhD, Michael.
International Participation in The Society of Thoracic Surgeons Adult Cardiac Surgery Database: From Institutional to National  Oz M. Shapira, MD, Orit.

International Participation in The Society of Thoracic Surgeons Adult Cardiac Surgery Database: From Institutional to National  Oz M. Shapira, MD, Orit.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Defining the Optimal Treatment of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis  Andrew J. Graham, MD, MS, Fiona M. Shrive,

Defining the Optimal Treatment of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis  Andrew J. Graham, MD, MS, Fiona M. Shrive,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D
Linetta B. Koppert, MD, PhD, Albertus N. van Geel, MD, PhD, Titia E

Linetta B. Koppert, MD, PhD, Albertus N. van Geel, MD, PhD, Titia E
Emanuela Taioli, MD, PhD, Andrea S

Emanuela Taioli, MD, PhD, Andrea S
Trimodal Therapy for Histologically Proven N2/3 Non–Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival  Volker Steger, MD, Thorsten.

Trimodal Therapy for Histologically Proven N2/3 Non–Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival  Volker Steger, MD, Thorsten.
Full-Thickness Resection With Myocutaneous Flap Reconstruction for Locally Recurrent Breast Cancer  Godehard Friedel, MD, FETCS, Thomas Kuipers, MD, Jürgen.

Full-Thickness Resection With Myocutaneous Flap Reconstruction for Locally Recurrent Breast Cancer  Godehard Friedel, MD, FETCS, Thomas Kuipers, MD, Jürgen.
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Similar presentations

Ads by Google